Breast cancer - gemcitabine: review decision - May 2010 information
History
A list of downloadable documents created during development.
Background information
-
-
Breast cancer - gemcitabine: review proposal - March 2010 information
-
Appendix A - a full list of the organisations contacted for this review
-
Appendix A - a full list of the organisations contacted for this review (PDF 59 KB)
-
Appendix B - proposal paper considered by the Institute's Guidance Executive
-
Appendix B - proposal paper considered by the Institute's Guidance Executive (PDF 112 KB)
Breast cancer - gemcitabine: Final appraisal determination
-
Breast cancer - gemcitabine: Final appraisal determination information
-
Final appraisal determination
-
-
Response to consultee, commentator and public comments on the ACD
-
Response to consultee, commentator and public comments on the ACD (PDF 153 KB)
-
Royal College of Nursing
-
-
Consultee and commentator comments on the ACD
-
Welsh Assembly Government
-
-
Southampton Health Technology Assessment Centre
-
-
Royal College of Radiologists
-
-
Royal College of Physicians
-
-
Royal College of Pathologists
-
-
Roche
-
-
National Collaborating Centre for Cancer
-
-
National Cancer Research Institute
-
-
Eli Lilly and Company Ltd
-
-
Department of Health
-
-
Cancerbackup
-
-
British Oncology Pharmacy Association
-
-
Breakthrough Breast Cancer
-
Gemcitabine for the treatment of metastatic breast cancer (appraisal consultation document)
Evidence considered
-
Evidence considered
-
Pre meeting brief
-
-
Breast cancer - gemcitabine: evidence review group report
-
Breast cancer - gemcitabine: evidence review group report (PDF 384 KB)
-
NICE clarification and responses
-
Manufacturer response
-
-
NICE clarification letter
-
-
Expert written personal statements
-
Wood
-
-
Verrill
-
-
Makris
-
-
Leadbeater
-
-
Heys
-
Breast cancer - gemcitabine - letter to consultees and commentators informing transer to STA process
-
Breast cancer - gemcitabine - letter to consultees and commentators informing transer to STA process
-
Breast Cancer - gemcitabine, draft scope
-
Breast Cancer - gemcitabine, draft scope
-
Breast Cancer - gemcitabine, provisional matrix of consultees and commentators
-
Breast Cancer - gemcitabine, provisional matrix of consultees and commentators
-
Breast Cancer - gemcitabine, provisional matrix of consultees and commentators (PDF 25 KB)